Table 1.
Results of laboratory investigations at initial (5 months) and last presentation (9 months).
| Test (reference range) | Acute presentation (district hospital) | At presentation (Tertiary hospital) | Last acute presentation (9 months old) |
|---|---|---|---|
| UREA (2.5–6.0 mmol/L) | 1.4 | 1 | 22.6 |
| CREATININE (14–34 umol/L) | 30 | 21 | 323 |
| CYSTATIN C (0.7–1.5 mg/L) | N/A | 1.52 | 5.26 |
| SODIUM (133–146 mmol/L) | 137 | 139 | 138 |
| POTASSIUM (3.5–5.0 mmol/L) | 3.3-4.5 | 4.5 | 6.2 |
| BICARBONATE (19–28 mmol/L) | 13 | 16 | 33 |
| CHLORIDE (95–108 mmol/L) | 109 | 113 | 87 |
| eGFR BY CREATININE (ml/min/1.73m2) | N/A | 107 | 8 |
| eGFR BY CYSTATIN-C | N/A | 48 | 15 |
| CALCIUM (mmol/L) | 2.31 | 2.11 | 1.51 |
| PHOSPHATE (1.2–2.2 mmol/L) | 1.97 | 1.79 | 2.74 |
| PTH (1.6–6.9 pmol/L) | 60 | 93.1 | 195.4 |
| ALP (77–540 u/L) | 524 | 505 | 198 |
| ALBUMIN (28–40 g/L) | 17 | 17 | 22 |
| URINE PCR (0–30 mg/mmol) | >2,000 | 2,189 | 1,975 |
| URINE ACR (0–3.0 mg/mmol) | N/A | 1978.5 | n/a |
| HEMOGLOBIN (100–130 g/L) | 90 | 84 | 83 |
| LYMPHOCYTES (3.3–11.5 × 109/L) | 0.9–1.6 | 1.52 | 0.58 |
| PLATELETS (150–560 × 109/L) | 391 | 457 | 415 |
| CHOLESTEROL (1.2–4.7 mmol/L) | N/A | 4.8 | 7.6 |
| ACTH (0–46 ng/L)* | 999 | ||
| CORTISOL (133–537 nmol/l)* | 61 | ||
| LH (1.7–8.6 IU/L), FSH (1.5–12.4 IU/L.)* | 71, 27 | ||
| TSH (0.2–5 mu/L)* | 27 | ||
| Free T4 (9–24 pmol/l)* | 10.5 |
*
Results prior to starting endocrine replacement therapy.